Shreegluco Biotech Private Limited - Company Profile

It is a food and beverages private limited company based in Bangalore South, Karnataka, India, established in 2012.
2012 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Shreegluco Biotech Private Limited

Shreegluco Biotech Private Limited, a active private limited company, was established on 24 February 2012 in Bangalore South, Karnataka, India. Engaging in organic & health foods within the manufacturing sector, it holds CIN: U15410KA2012PTC062704. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹45.00 Cr and a paid-up capital of ₹44.81 Cr.

It upholds a compliant status. Employing 341 professional, Its leadership includes Bysani Adinarayaguptha Srinath (Director), Bysani Srinath Mamatha (Director), Aishwarya Srinath Bysani (Director). Past directors included Bysani Seetharamasetty Adinarayanaguptha, Hemant Singh Rajawat, Nagaraja Venkatesh. It holds ₹304.56 Cr open charges and ₹34.54 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No- 306/1, 1St Floor , Centenary Building,, A.V Road , 1St Main Road , Chamarajpet, Bangalore South, Karnataka, 560018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15410KA2012PTC062704

  • Registration Number

    062704

  • Incorporation Date

    24 February 2012

  • Authorized Capital

    ₹45.00 Cr

  • Paid-Up Capital

    ₹44.81 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 45.00 Cr
  • Paid Up Capital ₹ 44.81 Cr
  • Company Age 14 Year, 7 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 304.56 Cr
  • Satisfied Charges ₹ 34.54 Cr
  • Revenue Growth **** 173.12%
  • Profit Growth **** -20.12%
  • Ebitda **** -6.48%
  • Net Worth 23.24%
  • Total Assets **** 41.07%
Company report

Shreegluco Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shreegluco Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shreegluco Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Bysani Adinarayaguptha Srinath Director 24 Feb 2012 Current
Bysani Srinath Mamatha Director 24 Feb 2012 Current
Aishwarya Srinath Bysani Director 31 Mar 2022 Current
Bysani Srinath Sanjana Director 04 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Mar 2022 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 12 Aug 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shreegluco Biotech.

Shreegluco Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 173.12% increase. The company also saw a substantial fall in profitability, with a 20.12% decrease in profit. The company's net worth Soared by an impressive increase of 23.24%.

Shreegluco Biotech revenue growth over time
Shreegluco Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 173.12%
*******
*******
*******
*******
Revenue from Operations
*******
 173.68%
*******
*******
*******
*******
Total Assets
*******
 41.07%
*******
*******
*******
*******
Profit or Loss
*******
 -20.12%
*******
*******
*******
*******
Net Worth
*******
 23.24%
*******
*******
*******
*******
EBITDA
*******
 -6.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shreegluco Biotech?

In 2023, Shreegluco Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,045,595,681.00

Satisfied Charges

₹345,400,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 153.53 Cr
  • Hdfc Bank Limited : 151.03 Cr
Latest Charge Details
Date Lender Amount Status
27 Dec 2023 Hdfc Bank Limited ₹1.70 Cr Open
19 Jul 2022 Hdfc Bank Limited ₹1.18 Cr Open
21 Apr 2022 Hdfc Bank Limited ₹6.71 Cr Open
21 Apr 2022 Hdfc Bank Limited ₹13.43 Cr Open
31 Jan 2022 Hdfc Bank Limited ₹107.87 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Shreegluco Biotech?

Shreegluco Biotech has a workforce of 341 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shreegluco Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreegluco Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shreegluco Biotech
Recent Activity within the Organization
  • Director Appointment

    Nagaraja Venkatesh was appointed as a Company Secretary was appointed as a Company Secretary on 27 Dec 2025 & has been associated with this company since 2 months 6 days . was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 107.87 Cr registered on 31 Jan 2022 with Charge ID 100534081 was modified on 21 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank of Rs. 152.21 Cr registered on 29 Dec 2016 with Charge ID 100073884 was modified on 24 Nov 2024. was completed.

  • Annual General Meeting

    Shreegluco Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Shreegluco Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.70 Cr with Charge ID 100914592 was registered on 27 Dec 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shreegluco Biotech Private Limited?

The CIN of Shreegluco Biotech Private Limited is U15410KA2012PTC062704.

Where is Shreegluco Biotech Private Limited headquartered?

Shreegluco Biotech Private Limited is headquartered at No- 306/1, 1St Floor , Centenary Building,, A.V Road , 1St Main Road , Chamarajpet, Bangalore South, Karnataka, 560018.

When was Shreegluco Biotech Private Limited incorporated?

Shreegluco Biotech Private Limited was incorporated on 24 February 2012.

Who are the current directors of Shreegluco Biotech Private Limited?

The current directors of Shreegluco Biotech Private Limited are

What is the primary industry of Shreegluco Biotech Private Limited?

The primary industry of Shreegluco Biotech Private Limited is Manufacturing.

Is Shreegluco Biotech Private Limited a listed company?

Shreegluco Biotech Private Limited is unlisted.

What is the capital structure of Shreegluco Biotech Private Limited?

The authorized capital of Shreegluco Biotech Private Limited is ₹45.00 Cr, and the paid-up capital is ₹44.81 Cr.

What is the compliance status of Shreegluco Biotech Private Limited?

The compliance status of Shreegluco Biotech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available